These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 22421449)
1. Administration of the PARP inhibitor Pj34 ameliorates the impaired vascular function associated with eNOS(-/-) mice. English FA; McCarthy FP; Andersson IJ; Stanley JL; Davidge ST; Baker PN; Walsh SK; Kenny LC Reprod Sci; 2012 Aug; 19(8):806-13. PubMed ID: 22421449 [TBL] [Abstract][Full Text] [Related]
2. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype. Kusinski LC; Stanley JL; Dilworth MR; Hirt CJ; Andersson IJ; Renshall LJ; Baker BC; Baker PN; Sibley CP; Wareing M; Glazier JD Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R86-93. PubMed ID: 22552791 [TBL] [Abstract][Full Text] [Related]
3. Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia. Walsh SK; English FA; Crocker IP; Johns EJ; Kenny LC Br J Pharmacol; 2012 Aug; 166(7):2109-16. PubMed ID: 22339234 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503 [TBL] [Abstract][Full Text] [Related]
7. Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction. Rueda-Clausen CF; Stanley JL; Thambiraj DF; Poudel R; Davidge ST; Baker PN Reprod Sci; 2014 Apr; 21(4):492-502. PubMed ID: 24084523 [TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice. Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904 [TBL] [Abstract][Full Text] [Related]
9. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597 [TBL] [Abstract][Full Text] [Related]
10. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Pacher P; Mabley JG; Soriano FG; Liaudet L; Szabó C Int J Mol Med; 2002 Jun; 9(6):659-64. PubMed ID: 12011985 [TBL] [Abstract][Full Text] [Related]
11. Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway. Bonnin P; Charriaut-Marlangue C; Pansiot J; Boutigny A; Launay JM; Besson VC Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911782 [TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442 [TBL] [Abstract][Full Text] [Related]
13. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass. Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289 [TBL] [Abstract][Full Text] [Related]
14. Postpartum reversal of the pregnancy-induced uterine artery remodeling in young, aging, and eNOS-deficient mice. van der Heijden OW; Essers YP; Wijnands E; Mey JG; Peeters LL; van Eys GJ Reprod Sci; 2009 Jul; 16(7):642-9. PubMed ID: 19351963 [TBL] [Abstract][Full Text] [Related]
15. [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage]. Fan HB; Wang YN; Geng DQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):712-3. PubMed ID: 20862804 [TBL] [Abstract][Full Text] [Related]